4//SEC Filing
Landsittel Michael 4
Accession 0001415889-24-013469
CIK 0001597264other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:05 PM ET
Size
7.1 KB
Accession
0001415889-24-013469
Insider Transaction Report
Form 4
Landsittel Michael
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2024-05-15$106.56/sh−1,364$145,348→ 71,617 total - Sale
Common Stock
2024-05-15$107.17/sh−2,486$266,425→ 72,981 total
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on December 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.94 to $107.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (3) in this form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.23 to $106.86 per share.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001651036
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:05 PM ET
- Size
- 7.1 KB